Recombinant Bovine Apolipoprotein A-I/APOA1 Protein (Yeast)，His

HMGB1 (High Mobility Group Box 1) is a non-histone chromatin-binding protein that plays a critical role in various cellular processes, including DNA repair, gene expression regulation, and inflammation modulation. As a key player in the immune response, HMGB1 acts as a damage-associated molecular pattern (DAMP), signaling stress and tissue injury, and facilitating the activation of innate immunity. Elevated levels of HMGB1 have been linked to numerous pathological conditions, including autoimmune diseases, cancer, and sepsis, highlighting its potential as a therapeutic target. The recombinant form of HMGB1, often referred to as HMG-1, has been developed for extensive research into its biological functions and mechanisms. By producing HMG-1 through recombinant DNA technology, researchers can dissect its interactions with various cellular partners, elucidate its signaling pathways, and evaluate its therapeutic implications in controlling inflammation and promoting tissue repair. The use of recombinant HMGB1 has also enabled the exploration of its role in modulating immune responses, providing insights into its potential use as a biomarker for disease diagnosis and prognosis. Overall, the study of HMGB1/HMG-1 recombinant protein continues to be a fertile ground for understanding its multifaceted roles in health and disease, paving the way for innovative therapeutic approaches.